Every bite, breath, or bug that enters your body passes through your gut. Luckily, your gut’s got a squad of immune cells ...

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine ...

Researchers from the California Institute of Technology and collaborating institutions have developed a novel HIV vaccine candidate, a new germline-targeting Env SOSIP trimer called 3nv.2, that is ...

His study showed that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of ...

Edward C. Holmes is a professor of biology and a Distinguished Senior Scholar in the Eberly College of Science at the Pennsylvania State University. Listen as Dr. Holmes discusses his research on ...

At CBS and ABC, he pursued news segments aimed at destigmatizing gay life and drawing attention to an epidemic that at the time was largely overlooked.

Hidden gene in leukemia virus could revolutionize HIV treatment Newly identified “viral silencer” explains HTLV-1’s stealth infection strategy; potential applications for HIV therapy.

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their viral loads to undetectable levels and then come off the medicine.

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at least three years.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. The decades-long push to develop an HIV vaccine has been riddled with ...

Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.